Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3595

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3595 9)

Pdp (68071 3595 9)
Label for Atorvastatin Calcium 40 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 90 tablets, Rx only. Includes multiple barcodes and reference to manufacturing and regulatory details. Warning to keep out of reach of children and storage instructions at controlled temperature 68-77°F is visible.*
FDA Label Image

Chemical Structure (Chemical Structure)

Chemical Structure (Chemical Structure)
Chemical structure of atorvastatin calcium, depicting its molecular components including the calcium ion and hydrate molecules, as presented in a structural diagram.*
FDA Label Image

Figure 1.jpg (Figure1)

Figure 1.jpg (Figure1)
A line chart showing cumulative incidence percentage over time in years comparing Atorvastatin and Placebo groups. The Atorvastatin group shows a lower cumulative incidence across approximately 3.5 years. The chart includes hazard ratio (HR=0.64, 95% CI 0.50-0.83) and p-value (p=0.0005).*
FDA Label Image

Figure 2.jpg (Figure2)

Figure 2.jpg (Figure2)
A cumulative hazard curve comparing Atorvastatin versus placebo over four years of follow-up. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage with Atorvastatin showing a lower hazard than placebo. The graph includes a hazard ratio (HR) of 0.63 with confidence interval and p-value.*
FDA Label Image

Figure 3.jpg (Figure3)

Figure 3.jpg (Figure3)
A line graph showing the percentage of subjects experiencing a cardiovascular event over time in years. Two lines represent atorvastatin doses: 10 mg (dashed line) and 80 mg (solid line), with the 80 mg dose showing a lower event rate over 5 years. The chart includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.